Most Clicked StoriesMore >


Ubl: 21st Century Cures Act would boost medtech evaluation

AdvaMed SmartBrief | Jul 27, 2015

The 21st Century Cures Act would give the FDA more sources of data for use in assessing medtech products and allow it to focus its resources on important review activities, AdvaMed President and CEO Stephen Ubl writes in this letter to the editor. The FDA, as well as doctor and patient groups, strongly support the bipartisan bill because it would promote the development of effective and safe treatments and give patients faster access to the products, Ubl writes. The New York Times (free-article access for SmartBrief readers) (07/24)


IPO could pull in $75M for GC Aesthetics

AdvaMed SmartBrief | Jul 28, 2015

X-spine Systems to be acquired by Bacterin

AdvaMed SmartBrief | Jul 29, 2015

Stomach-filling balloon gets FDA OK as weight-loss aid

AdvaMed SmartBrief | Jul 29, 2015

Tiny tool allows for more delicate surgery

AdvaMed SmartBrief | Jul 27, 2015

Cardiovascular segment drives Q2 profit growth for Boston Scientific

AdvaMed SmartBrief | Jul 24, 2015

Trial begins for Essential Medical's vascular closure device

AdvaMed SmartBrief | Jul 28, 2015

Supply deal with neurosurgery device firm renewed by Stryker

AdvaMed SmartBrief | Jul 24, 2015

Report: Worldwide market for bioabsorbable scaffolds set for growth

AdvaMed SmartBrief | Jul 24, 2015

Bill would streamline drug-device combo filings in U.S.

AdvaMed SmartBrief | Jul 28, 2015


Find AdvaMed SmartBrief Issues by Date:



ADVAMED News More >


Cybersecurity Webinar: Considerations for Connected Healthcare

AdvaMed SmartBrief | Jul 30, 2015

FDA Inspections, Warning Letters & CAPA Workshop

AdvaMed SmartBrief | Jul 30, 2015

Medical Device Clinical Trials: Operational Challenges and Opportunities

AdvaMed SmartBrief | Jul 29, 2015

Advertising and Promotion of Medical Devices

AdvaMed SmartBrief | Jul 29, 2015

Working with Private Payers: Advocating for Your Medical Technology in the Age of Reform

AdvaMed SmartBrief | Jul 28, 2015




Sign up for AdvaMed SmartBrief



Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more

Recent Poll view more polls


What concerns should medical device companies focus on in the coming year?

Chart.